Pfm Health Sciences, LP Kinnate Biopharma Inc. Transaction History

Pfm Health Sciences, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.73 - $17.99 $2.04 Million - $4.75 Million	-264,293 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$26.99 - $40.0 $2.09 Million - $3.1 Million	-77,612 Reduced 22.7%	264,293 $8.24 Million
Q4 2020 Feb 16, 2021	BUY	$36.35 - $45.25 $12.4 Million - $15.5 Million	341,905 New	341,905 $13.6 Million

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.